Study Stopped
recruitment difficulties
Pain and Schizophrenia
1 other identifier
interventional
83
1 country
5
Brief Summary
The aim of the investigators project is to explore the mechanisms of pain insensitivity in patients with schizophrenia, in order to prevent its invalidating consequences. The investigators will couple methods of experimental psychology with EEG and blood samplings, in order to distinguish the role of non-painful perception, attention, aversive effects, and pain expression, and the investigators will explore an original neurobiological hypothesis regarding the activation of opioid receptors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Aug 2011
Longer than P75 for not_applicable pain
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2010
CompletedFirst Posted
Study publicly available on registry
November 19, 2010
CompletedStudy Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedOctober 5, 2017
September 1, 2017
3.4 years
November 17, 2010
October 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Unpleasant stimuli
acute electrical stimulation
during experimental session
Unpleasant stimuli
emotional pictures
during experimental session
Study Arms (2)
Patients with schizophrenia
EXPERIMENTALHealthy controls
ACTIVE COMPARATORcontrols matched with patients on age, sex and education level
Interventions
Eligibility Criteria
You may qualify if:
- Patients with schizophrenia (criteria DSM IV) or healthy controls matched with patients on age, sex and education level
- years old
You may not qualify if:
- Past history affecting CNS
- Intake of psychotropic drugs, except for patients
- Metabolic disorder affecting sensory processing (diabetes)
- Intake of benzodiazepines
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Service de Psychiatrie Adulte2, Place Saint-Jacques - ZA 481, Centre Hospitalier Saint-Jacques
Besançon, 25030, France
Service de Psychiatrie Adulte, Secteur G11, Centre Hospitalier de Erstein, 13 route de Krafft
Erstein, 67152, France
Centre d'évaluation et de traitement de la douleur, Hôpitaux Universitaires de Strasbourg
Strasbourg, 67 091, France
Centre d'Investigation Clinique - Hôpitaux Universitares de Strasbourg
Strasbourg, 67091, France
Service de Psychiatrie - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anne Giersch, MD
University Hospital, Strasbourg, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2010
First Posted
November 19, 2010
Study Start
August 1, 2011
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
October 5, 2017
Record last verified: 2017-09